NCT06874426 The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
| NCT ID | NCT06874426 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Meningioma |
| Study Type | OBSERVATIONAL |
| Enrollment | 154 participants |
| Start Date | 2025-03-18 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 154 participants in total. It began in 2025-03-18 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, the research team will investigate the incidence and etiology of olfactory dysfunction following endoscopic endonasal skull base surgery, by combining clinical assessments with histomolecular analysis.
Eligibility Criteria
Inclusion Criteria: * Adult patients scheduled for endoscopic endonasal skull base surgery Exclusion Criteria: * Pre-existing anosmia * Patients has a history of previous endoscopic endonasal skull base surgery
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06874426 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Meningioma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06874426 currently recruiting?
Yes, NCT06874426 is actively recruiting participants. Contact the research team at julie.vanwaterschoot@kuleuven.be for enrollment information.
Where is the NCT06874426 trial being conducted?
This trial is being conducted at Leuven, Belgium, Frankfurt am Main, Germany, Leiden, Netherlands.
Who is sponsoring the NCT06874426 clinical trial?
NCT06874426 is sponsored by Universitaire Ziekenhuizen KU Leuven. The trial plans to enroll 154 participants.